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OBJECTIVES: Health care costs in Massachusetts (MA) are among the highest in 
the country. Thus, it is essential to gain an in-depth understanding of the pat-
terns of healthcare resource utilization and expenditures in the state. This study 
examines healthcare spending in the state by care setting, and compares where 
most spending occurs for Medicaid and private payers. METHODS: We used the 
2012 MA All Payer Claims Database, which included medical and pharmacy claims 
from all commercial payers and certain public programs (Medicare Part C only 
and Medicaid) to calculate healthcare utilization and expenditures for the state’s 
population (N= 6,549,289 individuals), including patient out-of-pocket payments. 
Traditional Medicare claims were not included in this analysis. We conducted 
descriptive analyses to calculate and compare total annual healthcare spending by 
site of service for Medicaid and private payers. RESULTS: Total healthcare spend-
ing for MA in 2012 amounted to $25 billion for private payers and $10.3 billion 
for the state Medicaid program. For private payers, pharmacy claims accounted 
for 27% of total healthcare spending, and the top sites of service by spending 
were hospital outpatient (26%), hospital inpatient (19%), and office visits (15%). 
For Medicaid, the biggest contributors to healthcare spending were office visits 
(22%), followed by hospital inpatient visits (17%), skilled nursing facility visits (16% 
versus only 0.3% for private), and home health visits (14% versus 1.5% in private), 
with pharmacy claims comprising 12% of spending. CONCLUSIONS: We identi-
fied differences in patterns of healthcare resource utilization and expenditures 
between Medicaid and private payers. These differences reflect demographic and 
pattern of care differences in the insured populations, as well as different payment 
policies and prices paid for services. In order to improve care quality, equity, and 
efficiency, it is important to understand how money is being spent by different 
segments of the healthcare market.
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OBJECTIVES: The adaption of technological advances in the past decades under-
scores the importance of measuring how efficiently hospitals are utilizing the 
growing labor force to provide health services. Our study aimed to assess California 
hospital productivity growth through addressing the severity of patient’s illness 
and outcomes of care. METHODS: We examined hospital productivity growth 
by analyzing patient discharge data from California for the period 2005 to 2011, 
among patient stays with a principal diagnosis of heart attack, pneumonia or 
heart failure. Productivity was defined by the ratio of the number of stays to 
total costs in each hospital-year. RESULTS: The study cohorts included 171,250 
patient stays at 358 hospitals with a primary diagnosis of heart attack, 336,111 
stays at 387 hospitals with pneumonia, and 389,413 stays at 383 hospitals with 
heart attack. Average costs per stay showed a slightly increasing trend from 2005 
to 2011 (from $22,965 to $23,669 in heart-attack stays, from $10,956 to $12,238 in 
pneumonia stays, and from $13,279 to $14,144 in heart-failure stays, all in 2011 
dollars). The average number of patient comorbidities increased by 37% for heart 
attack, 28% for pneumonia, and 87% for heart failure. A decreasing trend was 
observed in inpatient mortality rate, ranging from 26% for heart attack to 19% 
for pneumonia. Unadjusted annual productivity growth rates were significantly 
negative (-0.7% per year for heart-attack stays, -2.4% for pneumonia stays, and 
-1.5% for heart-failure stays). In contrast, after adjustment for patient severity of 
illness and inpatient survival, annual productivity growth rates became +0.4% per 
year for heart attack and +0.2% for heart failure; growth for pneumonia was no 
longer significantly negative. CONCLUSIONS: Accounting for patient severity and 
quality of care, as is appropriate, results in substantially more favorable trends in 
productivity growth at California hospitals.
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OBJECTIVES: As have many states, Mississippi Medicaid has witnessed a major 
shift from fee-for-service to managed care with in the last few years. In November 
2012, managed care enrollment was increased to almost 30% with the aim of 
improving health care service quality and reducing costs. However, the effects of 
this shift of patients to managed care has not been thoroughly evaluated. This 
project aimed to evaluate the impact of the shift of patients from fee-for-ser-
vice to managed care on health care utilization, quality and costs. METHODS: 
A retrospective analysis was conducted using Mississippi Medicaid FFS admin-
istrative claims and beneficiary eligibility data for the period November 1, 2011 
through December 31, 2013. A cohort of beneficiaries were identified who were 
continuously enrolled for this period and spent the first 12 months enrolled in 
fee-for-service and the next 12 months in managed care. Various outcomes were 
measured for the first 12-month and the second 12-month periods. An additional 
cohort of beneficiaries who were enrolled in fee-for-service for the whole dura-
tion of the study period were also followed on the same measures as a control 
group. RESULTS: The number of medications filled, number of office visits, inten-
sity of office visits, total pharmacy costs and total outpatients costs were found 
to increase after the shift to managed care. Days of inpatient stay, inpatient costs 
and ER costs all decreased. It appears that the shift to managed care has caused 
an increase in outpatient and pharmacy utilization and costs and a decrease in 
inpatient costs. CONCLUSIONS: The shift to managed care seems to have a mixed 
effect on health care use and spending for Mississippi Medicaid beneficiaries. 
Increased use of outpatient services while inpatient costs decrease may indicate 
a more appropriate level of care being used. Further analysis is needed to provide 
conclusive results.
OBJECTIVES: Waste in prescribing, dispensing, and consumption of medications in 
community settings significantly impacts the US Health Care System. This research 
examines waste associated with the medication use process which consists of any 
written prescriptions that are not (1) taken to a pharmacy to be filled, (2) taken 
to be filled but abandoned at the pharmacy, or (3) result in a medication being 
dispensed but not consumed as directed. The aim of this study is to quantify the 
costs of medication waste in the United States exclusive of impact on health out-
comes. METHODS: A review of published literature and data from the 2012 Medical 
Expenditure Panel Survey was used to quantify the number of prescriptions wasted 
at different stages of the medication prescribing and use process. Costs associated 
with medication waste included physician time and overhead lost writing prescrip-
tions, pharmacist time and overhead lost filling prescriptions, and ingredient costs 
of medications not used. RESULTS: In 2012, more than 8 million prescriptions were 
either unfilled or abandoned, and 70 million resulted in dispensed medications 
that were not used. The total cost of this waste was estimated at more than $14 
billion. This result excluded any additional costs associated with not achieving 
desired health outcomes. CONCLUSIONS: Patients who do not fulfill their role in 
the medication use process cause significant, avoidable costs to the health care 
system beyond the health outcomes not achieved.
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OBJECTIVES: Patients undergoing major surgeries often experience post-surgical 
complications. The impact of post-surgical complications on hospital costs has been 
extensively studied but the impact on margins remains a subject of controversy. We 
assessed the financial consequences of postsurgical complications in high-risk US 
Medicare patients undergoing specific procedures. METHODS: Data from Medicare 
patients with ≥1 comorbidity who had major cardiac, vascular, gastro-intestinal and 
orthopedic surgical procedures in 2011 were identified in the CMS database. Post-
surgical complications and financial information (in 2011 US$) were extracted from 
Medicare Standard Analytic Files and Hospital Cost Reports. Hospital margin was 
calculated as Medicare payments minus hospital costs. A total of 63 procedure codes 
(ICD-9-CM) were analyzed. RESULTS: Of 303,432 Medicare patients undergoing major 
surgery, mean costs were significantly higher for patients with at least one compli-
cation than for patients without any complication in each procedure category. For 
example, the mean cost per cardiac procedure patient with complication was $46,535, 
but only $32,887 per cardiac patient without complication. For each of the four proce-
dure categories, average hospital margins were approximately $1,500-$2,500 higher 
for patients without than with complications: $1,508 for cardiac patients, $2,336 for 
gastro-intestinal, $1,694 for orthopedic, and $2,515 for vascular patients (all p<0.0001). 
Weighted average margin were the Medicare cases with complication to be converted 
into cases without complication would be $1,870 higher per case.  For some procedure 
subgroups, the difference in average margin between cases with and without com-
plications was even higher, such as in pancreatectomy ($3,907 per case), aorto-iliac 
& peripheral bypass ($3,614), resection of rectum ($2,602), and partial hepatectomy 
procedures ($2,303) (all p<0.0001). CONCLUSIONS: Postsurgical complications have a 
significant impact on hospital margins. Enhanced Recovery Programs have potential 
not only to improve quality of care but also to improve hospital margins.
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